GLANZMANN THROMBASTHENIA DUE TO A 2-AMINO-ACID DELETION IN THE 4TH CALCIUM-BINDING DOMAIN OF ALPHA(IIB) - DEMONSTRATION OF THE IMPORTANCE OF CALCIUM-BINDING DOMAINS IN THE CONFORMATION OF ALPHA(IIB)BETA(3)
Rb. Basani et al., GLANZMANN THROMBASTHENIA DUE TO A 2-AMINO-ACID DELETION IN THE 4TH CALCIUM-BINDING DOMAIN OF ALPHA(IIB) - DEMONSTRATION OF THE IMPORTANCE OF CALCIUM-BINDING DOMAINS IN THE CONFORMATION OF ALPHA(IIB)BETA(3), Blood, 88(1), 1996, pp. 167-173
The integrin alpha(llb)beta(3), a calcium-dependent heterodimer, plays
a critical role in platelet aggregation. The alpha(llb) subunit of th
e heterodimer contains four highly conserved putative calcium-binding
domains in its extracellular portion. During studies of the molecular
basis of Glanzmann thrombasthenia in a child of mixed Caucasian backgr
ound whose platelets expressed little alpha(llb)beta(3) on their surfa
ce, we found the patient heterozygous for a two amino acid deletion in
the fourth alpha(llb) calcium-binding domain. When this alpha(llb) mu
tant was expressed in COS-1 cells, we found that the deletion did not
interfere with the assembly of alpha(llb)beta(3) heterodimers, but al
tered their conformation such that they were neither recognized by the
heterodimer-specific antibody A2A9 nor able to undergo further intrac
ellular processing or transport to the cell surface. These results sug
gest that the calcium-binding domains in alpha(llb) play an important
role maintaining the overall conformation of alpha(llb)beta 3. To conf
irm this suggestion, we deleted each of the four 12 amino acid calcium
-binding domains in alpha(llb) by in vitro mutagenesis and expressed t
he mutants along with pg in COS-1 cells. Each construct formed a heter
odimer with PSI but none of the heterodimers interacted with A2A9 or u
nderwent further intracellular processing. These data indicate that th
e calcium-binding domains in alpha(llb) are not involved in alpha(llb)
beta(3) heterodimer formation, but their presence is required for the
intracellular transport of alpha(llb)beta(3) to the cell surface. (C)
1996 by The American Society of Hematology.